Arome Science participates in Future Labs Live USA 2025 (Philadelphia)

Arome Science presents a semi-targeted metabolomics workflow—uniting targeted precision with untargeted discovery for decision-ready insights in clinical, microbiome, and pharma.

We’re thrilled to join Future Labs Live USA 2025 in Philadelphia, where Arome Science will showcase how cutting-edge metabolomics unlocks powerful health insights, fuels biomarker discovery, and advances microbiome research. Our CEO, Alexey Melnik, will represent us, sharing our innovative approach and connecting with leaders in lab automation, AI, data, sustainability, and operational excellence.

Spotlight on Semi-Targeted Metabolomics

At the event, we’re presenting our poster, “Semi-Targeted Metabolomics: Best of Both Worlds.” The semi-targeted approach blends the precision of targeted assays with the broad discovery potential of untargeted analysis. Propagating information between targeted and untargeted approaches can help  capture more metabolites with higher confidence, yielding richer biological context, and providing more actionable insights.

Our semi-targeted workflow is built for purpose. We tailor study designs to specific biological questions, working across diverse matrices. By balancing specificity with exploration, we quantify known biomarkers while uncovering new pathway signals for deeper investigation.

Download the poster (PDF) “Semi-Targeted Metabolomics: Best of The Both Worlds

From Study to Insight: Our Pipeline

Our process is streamlined yet robust:

  • Study Design: Customized to fit your research goals.
  • Data Acquisition: Using LC-MS/GC-MS and GC-MS with rigorous quality control.
  • Deconvolution: Turning raw spectra into clear, reliable data.
  • Biological Interpretation: Mapping features to pathways and phenotypes.
  • FAIR Data Dissemination: Ensuring results are accessible and reproducible.

We optimize every step – sample prep, acquisition, normalization, and annotation, to minimize variability and maximize reproducibility. We provide decision-ready results aligned with clinical or translational goals.

Why It Matters

Semi-targeted metabolomics delivers speed without sacrificing depth. Learn how it can be essential for:

  • Pharma & Biotech: Prioritizing leads and decoding mechanisms.
  • Clinical Research: Refining diagnostics and monitoring responses.
  • Agri- & Food Science: Connecting chemistry to phenotypes and environments.

Whether you’re running comparative cohort studies or longitudinal microbiome projects, our approach accelerates timelines while keeping discovery in play.

Join Us in Philadelphia

Arome Science is passionate about making metabolomics accessible and impactful. At Future Labs Live USA 2025, we’re excited to show how our semi-targeted strategy bridges precision and curiosity, helping researchers move from compounds to biomarkers with clarity. Stop by to meet Alexey, explore our poster, and see how we’re transforming metabolomics.

Table of Contents
Alexander Aksenov, Arome Science CSO
Alexander Aksenov

Ready to Start Your Analysis?

Contact us with your research question and sample types.
We’ll outline what’s feasible analytically and for a given budget.

Our Service

Related "Arome Science Updates" posts